Implementing Organizational Resources to Support Behavioral Change
ID: 357227Type: Posted
Overview

Buyer

National Institute of Corrections (USDOJ-BOP-NIC)

Award Range

$0 - $175K

Eligible Applicants

Others

Funding Category

Other

Funding Instrument

Cooperative Agreement

Opportunity Category

Other

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institute of Corrections is offering a cooperative agreement titled "Implementing Organizational Resources to Support Behavioral Change," aimed at providing community supervision agencies with essential resources for planning, adopting, and sustaining innovations that foster behavioral change in individuals under community supervision. This opportunity is not a request for applications but rather a continuation of Cooperative Agreement award 3CS17GLQ4, emphasizing the importance of organizational support in enhancing community supervision practices. The total estimated program funding is $175,000, with a single award expected, and interested parties can reach out to Cameron D. Coblentz at ccoblentz@bop.gov or by phone at 202-514-0053 for further information. The application deadline is set for December 6, 2024.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Community Engaged Research Resource Center (CERRC), aimed at addressing the overdose crisis among individuals involved in the criminal-legal system. This initiative seeks to engage various stakeholders in researching effective interventions for substance use disorders (SUD) and enhancing continuity of care between public health and public safety agencies, with a focus on community engagement and diversity, equity, and inclusion (DEI). The funding, capped at $750,000 per year, is available for projects that include engaging individuals with lived experience, creating public resources for community-engaged research, and conducting rapid turnaround research projects, with applications due by January 23, 2025. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-026.html.
    Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional), a federal grant opportunity aimed at funding research for developing and testing behavioral treatments for substance use and dependence. This initiative seeks to encourage research that tests the efficacy of behavioral interventions, examines mechanisms of behavior change, and optimizes treatment approaches, particularly for individuals with comorbidities and those in drug abuse treatment. The program is crucial for advancing substance abuse treatment and addressing health disparities, with a maximum funding amount of $450,000 available over three years. Interested applicants, including various educational institutions and community organizations, must submit their proposals by March 21, 2025, and can find additional information at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    National Community Anti-Drug Coalition Institute (NCI)
    Active
    Office of National Drug Control Policy
    The Office of National Drug Control Policy (ONDCP) is forecasting a grant opportunity titled the National Community Anti-Drug Coalition Institute (NCI), aimed at enhancing the capacity of community coalitions to implement evidence-based substance use prevention interventions. The primary objectives of this grant are to increase the effectiveness of community coalitions across the United States and to strengthen the technical assistance and training provided to these coalitions, particularly during the critical adolescent years when substance use initiation is most prevalent. With an estimated total program funding of $2.5 million and a single award anticipated, eligible applicants include national nonprofit organizations with expertise in community anti-drug coalitions. Interested parties should note that the estimated synopsis post date is December 9, 2024, with a closing date for applications on February 7, 2025, and the expected award date is March 10, 2025. For further inquiries, applicants can contact Helen Hernandez, Assistant Director for Drug Free Communities, at HelenHernandez@ondcp.eop.gov or by phone at 202-395-6665.
    HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional), aimed at addressing substance use disorder (SUD) within the criminal-legal system. This initiative focuses on enhancing research and effective interventions for individuals at risk of overdose during their transition through various stages of the justice system, with an emphasis on increasing access to medication for opioid use disorder (MOUD). The program will support multi-site studies, conduct cost analyses, and develop resources for practitioners, with a total funding amount of $800,000 allocated for one award. Interested applicants must submit their proposals by January 22, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional) to support research on effective interventions for individuals with substance use disorders (SUDs) within the criminal-legal system. This initiative aims to enhance the delivery of medication for opioid use disorder (MOUD) and address the overdose crisis by establishing multiple research centers that will collaborate with resource centers to improve treatment access and continuity of care for justice-involved populations. With a total funding budget of $5 million, the NIH plans to award five to seven grants, each with a maximum direct cost of $2.25 million, for projects lasting up to five years. Interested applicants must submit their proposals by January 22, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Promoting the Integration of Primary and Behavioral Health Care: Collaborative Care Model
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Promoting the Integration of Primary and Behavioral Health Care: Collaborative Care Model." This program aims to support the implementation of the Collaborative Care Model (CoCM), an evidence-based approach designed to integrate mental and substance use care within primary care settings, requiring recipients to collaborate with at least three primary care practices to establish the necessary staffing and systems. The total estimated funding for this program is $5,271,000, with approximately five awards expected to be made, and interested applicants, specifically state agencies, can reach out to Jenny Nate Cornelia at (240) 276-2135 or via email at PIPBHC@samhsa.hhs.gov for further information. The opportunity is currently posted, with an estimated synopsis posting date of February 28, 2025.
    Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for organizations seeking to change the recipient organization of specific NIH grants. This initiative allows eligible applicants, including higher education institutions, nonprofits, and various government entities, to submit applications for the transfer of grant awards, ensuring continuity in research projects. While the submission of applications does not guarantee approval for the transfer, the NIH encourages coordination with relevant institutes and adherence to grant policies to facilitate a smooth transition. Interested parties can find more information and submit inquiries via email at grantsinfo@nih.gov, with key submission dates starting from July 12, 2024, and the opportunity closing on July 12, 2027.
    Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), has announced the Innovation Corps (I-Corps) at NIH Program, aimed at enhancing the commercialization of biomedical innovations from Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I projects. This program provides administrative supplement awards to eligible small business concerns, facilitating entrepreneurship training and assisting teams in refining their commercialization strategies through customer discovery activities over an eight-week course. With a total funding pool of up to $2.64 million available for up to 48 awards, individual grants are capped at $55,000, and applications must be submitted by January 31, 2025. Interested applicants are encouraged to contact NIH Grants Information at grantsinfo@nih.gov for further guidance before applying.
    NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3), aimed at supporting research in behavioral and social interventions related to dental, oral, and craniofacial health. This funding opportunity encourages the development of clinical trials through a phased approach, beginning with a planning phase (UG3) lasting up to two years, which may transition into a clinical trial implementation phase (UH3) of up to five years, contingent upon meeting specific scientific milestones. The program emphasizes rigorous intervention studies that engage various stakeholders and adhere to the NIH Stage Model of intervention development, with applications due by 5:00 PM local time on January 7, 2025. For further inquiries, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link to the full announcement.
    HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Clinical Research Hubs, which requires a UM1 clinical trial. This initiative aims to address the opioid overdose crisis by researching effective interventions for individuals with substance use disorders (SUD) within the criminal justice system, focusing on optimizing treatment and enhancing collaboration between justice and community health agencies. The program anticipates funding 8-10 awards, with a total budget of approximately $14 million over five years, and emphasizes the importance of stakeholder engagement and diverse perspectives in the research process. Interested applicants must submit their proposals by January 22, 2025, and can find more information at the provided NIH grants link or contact NIH Grants Information at grantsinfo@nih.gov.